Bioinformatics analysis of shared biomarkers and immune pathways of preeclampsia and periodontitis
Fangyi Ruan,
No information about this author
Yinan Wang,
No information about this author
Ying Xiang
No information about this author
et al.
BMC Pregnancy and Childbirth,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Feb. 27, 2025
Epidemiological
evidence
indicates
that
preeclampsia
(PE)
is
associated
with
comorbidities
such
as
periodontitis
(PD).
However,
the
underlying
mechanism
remains
unclear.
To
enhance
our
understanding
of
their
co-pathogenesis,
this
research
investigated
shared
biomarkers
and
pathological
mechanisms.
We
systematically
retrieved
transcriptomic
datasets
from
Gene
Expression
Omnibus
database.
These
encompass
a
comparative
analysis
periodontium
without
PD
placenta
PE.
Differentially
Expressed
Genes
Analysis
Weighted
Go-expression
Network
(WGCNA)
were
used
to
identify
key
crosstalk
genes
in
patients
The
functional
characterisation
these
was
performed
using
enrichment
analysis.
Protein–protein
interaction
networks
machine
learning
methods
leveraged
hub
genes.
XG-Boost
algorithm
applied
construct
diagnostic
models
gain
insight
into
disease
aetiology.
identified
validated
by
single-cell
RNA
sequencing
ensure
robustness
biological
relevance.
A
total
55
identified,
which
primarily
enriched
immune-related
pathways
limma
WGCNA.
Among
them,
twenty-four
protein–protein
methods.
model
constructed
outperformed
other
two
(area
under
receiver
operating
characteristic
curve
[ROC]
=
0.7786
0.7454
for
PE
PD,
respectively).
Pathways
involving
mapped
Kyoto
Encyclopedia
Genomes
In
addition,
showed
expression
BIN2,
LYN,
PIK3AP1,
NEDD9
neutrophils
significantly
downregulated,
LYN
fibroblasts
endothelial
cells
consistently
upregulated.
Shared
immunologic
characterised
between
NEDD9,
suggesting
pathogenesis
could
pave
way
development
effective
diagnostic,
treatment,
management
strategies.
Language: Английский
Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1295 - 1295
Published: Feb. 3, 2025
Recurrent
pregnancy
loss
(RPL)
is
defined
as
the
occurrence
of
two
or
more
consecutive
losses
before
24
weeks
gestation.
It
affects
3-5%
women
who
are
attempting
to
conceive.
RPL
can
stem
from
a
variety
causes
and
frequently
associated
with
psychological
distress
diminished
quality
life.
By
contrast,
recurrent
implantation
failure
(RIF)
refers
inability
achieve
successful
after
three
high-quality
embryo
transfers
at
least
instances
egg
donation.
RIF
shares
several
causative
factors
RPL.
The
immunological
underpinnings
these
conditions
involve
alterations
in
uterine
NK
cells,
reductions
M2
macrophages
myeloid-derived
suppressor
an
increased
Th1/Th2
ratio,
decreased
Treg/Th17
presence
shared
≥3
HLA
alleles
between
partners,
autoimmune
disorders.
Various
therapeutic
approaches
have
been
employed
address
concerns,
achieving
varying
degrees
success,
although
some
therapies
remain
contentious
within
medical
community.
This
review
intends
explore
implicated
analyze
treatments
for
conditions,
which
may
include
steroids,
intravenous
immunoglobulins,
calcineurin
inhibitors,
anti-TNF
antibodies,
intralipid
infusions,
granulocyte
colony-stimulating
factor,
lymphocyte
immunotherapy.
Language: Английский
Decoding immune tolerance in infertility: Exploring immune pathways and non-coding RNAs as pioneering biomarkers and therapeutic targets
Harikumar Pallathadka,
No information about this author
Abdulrahman Qais Khaleel,
No information about this author
Ahmed Hjazi
No information about this author
et al.
Human Immunology,
Journal Year:
2025,
Volume and Issue:
86(3), P. 111264 - 111264
Published: Feb. 20, 2025
Language: Английский
Maternal IgE Influence on Fetal and Infant Health
Jozef Balla,
No information about this author
Abhay P. S. Rathore,
No information about this author
Ashley L. St. John
No information about this author
et al.
Immunological Reviews,
Journal Year:
2025,
Volume and Issue:
331(1)
Published: April 25, 2025
ABSTRACT
Immunoglobulin
E
(IgE)
is
the
most
recently
discovered
and
evolved
mammalian
antibody
type,
best
known
for
interacting
with
mast
cells
(MCs)
as
immune
effectors.
IgE‐mediated
antigen
sensing
by
MC
provides
protection
from
parasites,
venomous
animals,
bacteria,
other
insults
to
barrier
tissues
exposed
environment.
IgE
MCs
act
inflammation
amplifiers
response
adjuvants.
Thus,
production
memory
formation
are
greatly
constrained
require
specific
licensing.
Failure
of
regulation
gives
rise
allergic
disease,
one
top
causes
chronic
illness.
Increasing
evidence
suggests
allergy
development
often
starts
early
in
life,
including
prenatally,
maternal
influence
being
central
shaping
offspring's
system.
Although
exists
before
birth,
an
endogenous
source
IgE‐producing
B
has
not
been
identified.
This
review
discusses
mechanisms
transfer
into
offspring,
its
interactions
offspring
antigen‐presenting
cells,
consequences
allergen
sensitization
development.
We
discuss
multifaceted
effects
pre‐existing
IgG,
IgE,
their
glycosylation
on
functionality
progeny.
Understanding
predisposing
life
may
allow
targeting
existing
therapeutics
guide
new
ones.
Language: Английский